SCHEMBL19413482

SCHEMBL19413482

CCCCCC(CCC)c1ccc(O)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 9/20 0.53
▸ ESR2 Q92731 7/20 0.53
▸ DEGS1 O15121 2/20 0.41
▸ NR5A1 Q13285 1/20 0.38
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ STAT3 P40763 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ADRA2A P08913 2/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ TACR2 P21452 2/20 0.36
▸ SLC6A2 P23975 2/20 0.36
▸ SLC6A4 P31645 2/20 0.36
▸ SLC6A3 Q01959 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SHBG P04278 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18672423 0.94 ESR1 (0.53) ESR1ESR2DEGS1NR5A1NPC1
SCHEMBL25015841 0.81 KDM4E (0.37) ESR1ESR2MAPTKDM4EALDH1A1
SCHEMBL18879371 0.81 ESR1 (0.55) ESR1ESR2DEGS1NR5A1NPC1
SCHEMBL22166120 0.79 APLNR (0.36) ESR1ESR2
SCHEMBL19003485 0.77 POLB (0.38) SMN1; SMN2KDM4E
SCHEMBL25573950 0.77 KDM4E (0.46) SLC6A3KDM4EALDH1A1HSD17B10
SCHEMBL18948444 0.77 KDM4E (0.39) ESR1ESR2MAPTKDM4EALDH1A1
SCHEMBL24805811 0.76 DEGS1 (0.39) ESR1DEGS1NR5A1NPC1MAPT
SCHEMBL23871083 0.75 MAPK1 (0.42) ESR1ESR2NPC1MAPTRAB9A
SCHEMBL18596818 0.75 APLNR (0.38) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9777002-B2 Inhibitors of the renal outer medullary potassium channel MERCK SHARP & DOHME CORP. (US) 2017-10-03 — — US disclosed
Send feedback